Safety and Efficacy of PCSK9 Inhibitor Treatment in Heart Transplant Patients

被引：10
|
作者：
Di Nora, Concetta [1 ]
Sponga, Sandro [1 ]
Livi, Ugolino [1 ]
机构：
[1] Azienda Sanit Univ Integrata Udine, Dept Cardiothorac Sci, Udine, Italy
来源：
TRANSPLANTATION | 2019年 / 103卷 / 03期
关键词：
RISK;
D O I：
10.1097/TP.0000000000002520
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E58 / E58
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of the PCSK9 inhibitors in the treatment of dyslipidemia in chronic kidney disease
    Quiroga, Borja
    Munoz Ramos, Patricia
    Alvarez Chiva, Vicente
    NEFROLOGIA, 2020, 40 (05): : 499 - 505
  • [2] MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment
    Burnett, John R.
    Hooper, Amanda J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (10) : 873 - 878
  • [3] PCSK9 inhibition in patients with heart failure: neutral or harmful intervention?
    Niessner, Alexander
    Drexel, Heinz
    EUROPEAN HEART JOURNAL, 2022, 43 (16) : 1566 - 1568
  • [4] A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
    Koh, Kwang K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18)
  • [5] Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
    Li, Tingting
    Zhang, Yingyi
    Cong, Hongliang
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [6] Is a PCSK9 Inhibitor Right for Your Patient? A Review of Treatment Data for Individualized Therapy
    Beltran, Roman A.
    Zemeir, Kyle J.
    Kimberling, Chase R.
    Kneer, Mary S.
    Mifflin, Michelle D.
    Broderick, Tom L.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (24)
  • [7] PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?
    Xiao, Ying
    Ba, Zhengqing
    Pang, Shurui
    Liu, Dong
    Wang, Hao
    Liang, Hanyang
    Wang, Yong
    Yuan, Jiansong
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (11)
  • [8] Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis
    Xiao, Guoguang
    Gao, Shan
    Xie, Yongmei
    Wang, Zhiling
    Shu, Min
    MEDICINA-LITHUANIA, 2024, 60 (10):
  • [9] A systematic approach for successful PCSK9 inhibitor prescribing in clinical practice
    Knickelbine, Thomas
    Jia, Lori
    White, Susan K.
    Garberich, Ross F.
    Oberembt, Sandra J.
    Wills, Samantha
    Miedema, Michael D.
    Brilakis, Emmanouil S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (02) : 265 - 271
  • [10] Doubling of Hemoglobin A1c on PCSK9 Inhibitor Therapy
    Memon, Raafia
    Malek, Rana
    Munir, Kashif M.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (01) : E17 - E18
12345